Prince Mario-Max Schaumburg-Lippe: The Waxman Luncheon 2026 Last Tickets For The Most Powerful Charity Luncheon Of The Year!

The Waxman Luncheon 2026 Sets the Standard for Purpose and Style – Get Your Ticket NOW!

An elegant New York gathering unites philanthropy, fashion, and science to advance lifesaving cancer research. New York’s PR Powerwoman Noral Lawlor reps the Luncheon of the year: BEST GUESTLIST, BEST PROGRAM, BEST CAUSE and nowhere else does doing good feel better!

https://waxmaninstitute.org/events/12th-annual-waxman-luncheon#tickets

In the refined cadence of New York’s philanthropic calendar, certain gatherings carry a deeper resonance, extending far beyond their setting to shape conversations that matter. The 12th Annual Waxman Luncheon emerges as one such occasion, where purpose and elegance meet with unmistakable clarity. Scheduled for May 6, 2026, this highly anticipated event draws together a distinguished community committed to one of the most urgent causes of our time, advancing cancer research through collective action and support.

At Riverpark, a venue synonymous with understated sophistication and sweeping views, the afternoon unfolds with intention. From the moment guests arrive, there is a palpable sense that this is not merely a social engagement, but a meaningful convergence of individuals who understand the stakes. The Samuel Waxman Institute for Aging and Cancer stands at the heart of this gathering, anchoring the event in its mission to explore the intricate relationship between aging and cancer.

The Institute’s work reflects a forward-thinking approach that recognizes aging as the most significant risk factor in the development of cancer. This perspective has guided a new era of scientific exploration, one that seeks to bridge disciplines and foster collaboration across institutions. The luncheon serves as both a celebration of progress and a catalyst for continued discovery, ensuring that each contribution supports tangible advancements in prevention, detection, and treatment.

Philanthropy at this level carries a certain elegance, expressed not only through generosity but through intention. The Waxman Luncheon has cultivated a reputation for bringing together leaders from diverse spheres, including real estate, fashion, science, and advocacy. This blend of perspectives enriches the experience, creating a dynamic environment where ideas and commitments intersect.

The 2026 luncheon honors Mary Slattery and Alexandra Adame, two figures whose dedication to the cause reflects a broader commitment to meaningful impact. Their recognition underscores the importance of individual leadership within the collective effort to address cancer’s global reach. Their presence adds a layer of personal narrative to the event, reminding attendees that progress is driven by both institutional strength and individual conviction.

Fashion plays an integral role in shaping the identity of the luncheon, adding a dimension that speaks to creativity and cultural influence. Safiyaa’s involvement as the fashion presenter introduces a refined aesthetic that complements the event’s philanthropic purpose. The presentation is not merely a display of design, but an extension of the event’s ethos, where artistry supports advocacy in a seamless expression of modern luxury.

The setting at Riverpark enhances the experience, offering a space that feels both intimate and expansive. The design of the venue allows for natural movement and interaction, encouraging conversations that extend beyond formalities. It is within these exchanges that the true spirit of the luncheon emerges, as guests share insights, build connections, and reinforce their shared commitment.

Beneath the elegance lies a carefully structured program designed to maximize impact. Live and silent auctions provide opportunities for guests to contribute directly, transforming moments of engagement into measurable support for research initiatives. Each bid represents more than a transaction, it signifies a shared investment in the future of cancer treatment.

The Samuel Waxman Institute’s affiliation with The Mark Foundation for Cancer Research further strengthens its position within the global research community. This partnership reflects a commitment to collaboration at the highest level, ensuring that resources are directed toward projects with the greatest potential for breakthrough discoveries. The luncheon serves as a vital conduit for this work, translating awareness into action.

A Legacy of Scientific Commitment

The history of the Samuel Waxman Institute is rooted in decades of dedication to advancing cancer research. Building on the legacy of the Samuel Waxman Cancer Research Foundation, the Institute has supported more than 200 scientists worldwide, distributing over $120 million in funding since its inception. This sustained effort has created a foundation upon which new discoveries continue to emerge.

The Institute’s focus on aging biology represents a significant shift in how cancer is understood and addressed. By examining the processes that contribute to cellular aging, researchers are uncovering pathways that may lead to more effective interventions. This approach holds the promise of treatments that are both more precise and less invasive, improving outcomes for patients across diverse populations.

Events such as the Waxman Luncheon play a crucial role in sustaining this momentum. They provide not only financial support but also a platform for raising awareness about the Institute’s work. The visibility generated by the luncheon extends its impact beyond the immediate audience, reaching a broader community that can engage with and support the mission.

The leadership behind the event reflects a network of individuals deeply invested in its success. Event Chairs Marion N. Waxman, Susan Pernick, and Dina Koutroumanis guide the vision with clarity and purpose. Their leadership is complemented by Event Co-Chairs Erica Linden-Fineberg, Nancy Litman, and Helen Vaysman, along with a dedicated committee that includes Sandy Ackerman, Jessica DiPalma, Orital Karelic, Norah Lawlor, Lorri Scott, and Randi Schatz.

Each of these contributors brings a unique perspective, ensuring that the luncheon reflects a balance of tradition and innovation. Their collective efforts shape an experience that is both seamless and impactful, reinforcing the event’s position as a cornerstone of philanthropic engagement in New York.

Where Style and Substance Converge

The integration of fashion within the luncheon speaks to a broader understanding of influence. Style becomes a vehicle for storytelling, a way to engage audiences who may not traditionally intersect with scientific discourse. Safiyaa’s presentation exemplifies this approach, offering a visual narrative that aligns with the event’s purpose.

Guests experience a carefully curated environment where every detail contributes to the overall narrative. From the floral arrangements to the pacing of the program, the luncheon reflects a commitment to excellence that mirrors the standards of the Institute itself. This attention to detail ensures that the event resonates on multiple levels, leaving a lasting impression.

The presence of leaders from the fashion community adds a layer of cultural relevance, highlighting the role of creative industries in shaping public engagement. Their participation reinforces the idea that philanthropy can be both impactful and inspiring, bridging the gap between different spheres of influence.

As the afternoon progresses, the sense of unity among attendees becomes increasingly evident. Conversations shift from introductions to shared goals, reflecting a collective understanding of the importance of the cause. This transformation is one of the defining features of the Waxman Luncheon, turning a gathering into a movement.

The auction segments introduce moments of anticipation, drawing guests into the process of giving in a dynamic and engaging way. Each item represents an opportunity to contribute, with proceeds directly supporting research initiatives that have the potential to change lives.

A Future Defined by Innovation

Looking ahead, the significance of the Waxman Luncheon continues to grow. As research evolves and new challenges emerge, the need for sustained support becomes even more critical. The luncheon stands as a testament to what can be achieved when communities come together with a shared purpose.

The work of the Samuel Waxman Institute extends far beyond the confines of the event, influencing the trajectory of cancer research on a global scale. Its commitment to collaboration and innovation positions it at the forefront of efforts to understand and combat the disease.

The 2026 luncheon captures this momentum, offering a moment to reflect on progress while looking toward the future. It is an occasion defined by clarity of purpose, where every element contributes to a larger vision of improved health outcomes and expanded possibilities.

In this setting, philanthropy is not an abstract concept but a tangible force, expressed through action and engagement. The luncheon embodies this principle, transforming generosity into meaningful impact that extends far beyond the event itself.

As guests depart, the impression left by the afternoon lingers, not as a fleeting memory but as a reminder of what can be accomplished through collective effort. The Waxman Luncheon continues to set a standard for how events can unite elegance and purpose in service of a vital cause.

 

Prince Mario-Max Schaumburg-Lippe: Shine Humanity’s Los Angeles Fundraiser Prepares to Unite Community Support

A powerful call from Dr Syed Salman Naqvi brings fresh momentum to a mission grounded in compassion and global care.

The upcoming Shine Humanity Fundraiser in Los Angeles has emerged as a meaningful moment for supporters who recognize the value of expanding access to healthcare for underserved communities. The message shared by Dr Syed Salman Naqvi MD places a clear focus on participation, community engagement, and the ongoing mission that has guided Shine Humanity for years. His outreach highlights the importance of gathering supporters across the United States and encourages them to join an event that reflects sincerity, purpose, and collective goodwill.

At the center of the announcement is the vivid event poster featuring children whose lives reflect the direct impact of the organization’s medical outreach. Their expressions, captured with calm and natural clarity, reinforce the purpose behind this gathering. Shine Humanity continues to offer healthcare where it is needed most, and the visual reminder of the young faces served by the organization provides a powerful entry point into the mission’s significance.

The forthcoming fundraiser, set to take place at the Hyatt Regency in Long Beach, reflects Shine Humanity’s long-standing commitment to accessible and compassionate healthcare. Its placement in Southern California aligns the event with a region known for vibrant philanthropic engagement. The selection of the Hyatt Regency underscores an intention to create a welcoming environment where supporters can meet, learn, and renew their dedication to the work being done across global communities.

Dr Syed Salman Naqvi’s role in this announcement is pivotal. His message brings personal encouragement and a sense of unity to the event. His leadership and visibility within the Shine Humanity community strengthen the momentum behind the fundraiser and encourage broader participation. His invitation reaches well beyond a simple reminder, offering an open call to anyone in the United States who wishes to be part of a meaningful cause.

The Save the Date announcement emphasizes the clarity and sincerity that define Shine Humanity’s mission. The organization’s tagline, Healthcare for the under-served, accompanies images of children who represent families and communities strengthened by access to care. Their presence centers the event within the reality of the work being done, serving as a grounding reminder of the organization’s purpose.

Supporters who attend the Los Angeles fundraiser will have the opportunity to engage with stories of progress from medical teams and project leaders who continue to expand health services across regions where care is limited. Shine Humanity’s programs, shaped by years of consistent effort, rely heavily on the support generated through events like this one. The gathering will provide insight into ongoing programs and introduce future initiatives that require sustained energy and community involvement.

The Long Beach venue places the event at a crossroads of accessibility and community spirit. With its reputation for hosting significant cultural and philanthropic gatherings, the Hyatt Regency offers a setting that supports meaningful interaction and thoughtful programming. Attendees can expect an afternoon shaped by firsthand perspectives, organizational updates, and opportunities to join the mission in impactful ways.

The children in the event image form an essential part of the narrative. Their clothing, expressions, and presence in the natural environment around them reflect the authenticity of Shine Humanity’s work. Their appearance is not symbolic; it is a direct representation of those who benefit from medical support, educational outreach, and access to essential care facilitated by the organization and its donor community.

As the fundraiser draws closer, Dr Naqvi’s message continues to resonate. His encouragement fosters a sense of shared responsibility among supporters and reminds everyone connected to Shine Humanity that the success of the mission depends on collective action. His involvement brings visibility to an event designed to inspire generosity, strengthen community ties, and elevate the impact of ongoing healthcare projects.

The Save the Date announcement serves as a point of unity, bringing together physicians, donors, volunteers, and individuals dedicated to creating meaningful change. The event highlights the continuity of Shine Humanity’s mission and celebrates the network of supporters who sustain it. The simplicity of the visual announcement reflects the organization’s direct and purposeful approach to global health.

Shine Humanity’s presence at the Hyatt Regency will offer an opportunity to look ahead as well as acknowledge progress. Attendees will learn how the organization continues to meet evolving healthcare needs and how their involvement directly supports children and families who rely on these services. Each element of the event reinforces the belief that accessible healthcare is achievable when communities come together with shared conviction.

The call to join the fundraiser creates an inclusive environment that welcomes long-standing supporters and newcomers alike. It carries a message of optimism grounded in real results. Every person involved contributes to strengthening programs that support children like those pictured in the announcement, and the fundraiser offers a space to deepen this commitment.

The focus on Los Angeles for the 2026 gathering reflects Shine Humanity’s dedication to building strong connections within the United States. The region’s philanthropic culture aligns naturally with the goals of the organization, making it an ideal location for a gathering that blends awareness, engagement, and strategic growth.

The story behind this event begins with the children whose lives are directly impacted by Shine Humanity and extends to supporters like Dr Naqvi, whose dedication and active outreach make the mission stronger. Their combined presence in the announcement creates a complete and compelling message: this fundraiser is an opportunity to participate in a mission centered on compassion, care, and global well-being.

As the organization prepares for its Los Angeles fundraiser, the shared commitment of its supporters continues to shape its future. Events like this one ensure that healthcare remains accessible to underserved communities and that the stories of those receiving care remain at the heart of every initiative.

The message shared by Dr Naqvi serves as a timely and inspiring invitation. It encourages individuals across the country to come together for an afternoon of purpose and progress. The Los Angeles fundraiser stands as a moment to honor the mission, recognize ongoing achievements, and build new pathways for expanded healthcare access.

Prince Mario-Max Schaumburg-Lippe: Richie Hosein Launches FreeHealth.AI to Revolutionize Global Care

Healthcare entrepreneur Richie Hosein has unveiled FreeHealth.AI, a global movement that aims to make intelligent, high-quality healthcare accessible and free for everyone, regardless of location.

FreeHealth.AI introduces a comprehensive, AI-powered ecosystem that merges digital twin modeling, adaptive learning, and predictive analytics to create a proactive healthcare model centered on prevention and personal empowerment. Conceived after more than two decades of leadership in the healthcare industry, Hosein’s vision reflects his determination to address systemic gaps and inefficiencies that continue to define much of modern medicine.

The FreeHealth platform presents an array of integrated features that reshape how individuals manage their wellbeing. Concierge MD offers a fully interactive digital twin capable of predicting and preventing health issues through genomic modeling and advanced AI dialogue. Health Loop connects users to family and friends for shared motivation and wellness tracking, while AutoBook intelligently schedules appointments and synchronizes them with personal calendars. Care Advocate ensures patients are heard and supported during consultations, and Health ID provides biometric authentication with secure, FDA-approved vital monitoring.

Complementing these tools is Medimart, a dynamic marketplace offering transparent medical pricing and coverage options, and Medilink, a unified platform for all connected health devices and records. My Data reinforces FreeHealth’s commitment to individual control, allowing users to grant permission for data use and receive compensation, preserving both transparency and trust.

Richie Hosein describes FreeHealth as more than a technology company. It is an initiative designed to redefine how people experience care. His belief is that healthcare should no longer depend on reactive systems that treat illness after onset, but instead embrace constant awareness and early intervention. Hosein envisions AI as a daily utility capable of serving as a “check engine light” for the human body, continuously guiding preventive and diagnostic care before disease develops.

The timing of FreeHealth’s introduction coincides with public concerns over the fragility of current healthcare systems. Hosein’s initiative responds to the growing perception that the traditional medical model is constrained by its episodic nature, emphasizing sick care rather than sustained wellness. By building an infrastructure that focuses on lifelong prevention, Hosein joins other forward-thinking leaders seeking to reimagine how health is maintained at scale.

Sumit Nagpal, Chair and Chief Executive Officer of Cherishhealth.com, has publicly expressed his support for the movement, noting that FreeHealth represents an emerging generation of ventures dedicated to continuous, holistic wellbeing. His remarks underscore a shared recognition across the health technology sector that innovation must move beyond incremental improvement toward full reconfiguration of the patient experience. Cherish Health is the worlds first patented home health monitoring system using radar so there is no camera in your house violating anyones privacy. The Cherish device detects falls and keeps the aging population safe at home.

Sulaiman Mustapha, serving as Chief Innovation Officer at FreeHealth, reinforces the platform’s emphasis on inclusivity and autonomy. His work focuses on ensuring that FreeHealth remains personal, private, and universally accessible. Mustapha, known for his inventive approach and technical consultancy, describes the initiative as a digital home for health, comparable in unifying influence to transformative technology companies that previously redefined communication and mobility. His statement highlights the goal of establishing FreeHealth as a central destination for healthcare connection, community, and progress.

The platform’s use of real-time data from facial scans, wearables, ambient sensors, and biological metrics allows the creation of a continuously evolving digital twin—a mirror of an individual’s health that adapts with every heartbeat and lifestyle change. This live model provides users with early warnings, custom guidance, and constant optimization, shifting the balance of control from institutions to individuals.

By consolidating diverse medical technologies within a single digital environment, FreeHealth positions itself as both a practical solution and a social movement. It bridges scientific precision with user-friendly design, offering a seamless blend of healthcare innovation and personal agency. Hosein’s approach unites healthcare professionals, engineers, and data experts in pursuit of a single objective: making proactive, predictive, and participatory health accessible to everyone.

As FreeHealth.AI begins its international rollout, it stands as an invitation to reimagine what healthcare can be when intelligence, accessibility, and compassion converge. The initiative reflects Richie Hosein’s enduring belief that progress in healthcare should never depend on privilege, but on the universal right to live with awareness and care.

* His Highness and Excellency Global Peace Ambassador Dr. PRINCE MARIO-MAX SCHAUMBURG-LIPPE is a working Royal, award winning TV- and Event-Host, Bertelsmann Randomhouse author, Public Speaker and Philanthropist ♔ Prince Mario-Max is the son of Royal Dignitaries H.H. Dr.h.c. Prince Waldemar and H.H. Dr. Princess Antonia of Schaumburg-Lippe. His Grandmother is H.R.H. Princess Feodora of Denmark. Therefore they are the Royal Danish Nachod Line of The Princes of Schaumburg-Lippe, the Founding Family of Hamburg, Lübeck and Kiel. ♔ Instagram https://www.instagram.com/princemariomax/ Website http://www.schaumburglippe.org Facebook https://www.facebook.com/zuschaumburglippe X-Twitter https://twitter.com/schaumburglippe Linkedin https://www.linkedin.com/in/prince-mario-max-schaumburg-lippe-1879978a

Prince Mario-Max Schaumburg-Lippe: The White Cross Ball of New York City Launches Its Elegant Silent Auction

An evening of timeless generosity and refined glamour supports the Order of Malta’s centuries-old mission of care.

As the city prepares for one of its most distinguished annual galas, the White Cross Ball of New York City opens its silent auction with a dazzling array of rare experiences, luxurious indulgences, and meaningful opportunities to give. Set for Friday, November 7, the evening will once again honor the enduring humanitarian legacy of the Order of Malta, a charitable institution whose service to the sick and vulnerable spans more than nine centuries.

Each year, the White Cross Ball gathers patrons of philanthropy, culture, and high society in a spirit of compassion and celebration. The 2025 edition continues this proud tradition, combining a formal dinner, lively music, and elegant company with the shared purpose of aiding those most in need. With only a limited number of dinner tickets remaining, anticipation around this year’s event has reached an early peak, further fueled by the opening of its online silent auction.

The auction offers participants a chance to contribute directly to global humanitarian causes while discovering a collection of experiences that reflect refinement and artistry. Each item embodies a blend of luxury and generosity, curated to delight connoisseurs of travel, craftsmanship, and fine living. The proceeds, as always, will benefit the charitable missions of the Order of Malta, whose programs deliver medical care, social support, and emergency relief around the world.

Among the highlights of this year’s silent auction is an extraordinary voyage through the Mediterranean with PONANT EXPLORATIONS, sailing from Nice to Malta from May 25 to June 1, 2026. This journey offers an intimate exploration of one of the world’s most storied seas aboard a vessel known for its elegance, comfort, and personalized service. It is an experience that celebrates both discovery and tranquility, ideal for those who appreciate travel as an art form.

Fashion enthusiasts will be drawn to the opportunity to design a bespoke pair of Stubbs & Wootton loafers, a hallmark of tailored sophistication that reflects the wearer’s individual style. Each pair is hand-finished with meticulous attention to detail, ensuring that the final result becomes a lasting statement of craftsmanship and personality.

For collectors and admirers of fine writing instruments, the Montblanc Great Characters James Dean Limited Edition 1931 Fountain Pen stands out as a piece of functional artistry. Designed in tribute to one of cinema’s most iconic figures, this pen captures both historical reverence and creative excellence, making it a rare acquisition for the discerning patron.

The pleasures of good wine also make a graceful appearance among the offerings. Glenelly’s Lady May Stellenbosch, a South African red wine celebrated for its balance and elegance, promises to elevate any gathering. This particular selection invites the bidder to bring a note of sophistication to their next dinner or celebration, while supporting a greater purpose through their generosity.

Wellness and beauty find their place in the auction through L’Avenue Dermatology & Aesthetics, a private sanctuary renowned for its advanced dermatologic care and aesthetic expertise. With exclusive memberships for adults, brides, and new mothers, it offers a rejuvenating experience that merges medical precision with serene luxury. The packages serve as an invitation to self-care grounded in excellence.

For those planning significant life moments, wedding photography by Alena Kostromina presents a chance to immortalize the day with artistry and grace. Her photography, marked by its luminous composition and timeless style, captures the emotion of celebration with technical mastery and subtle beauty.

Culinary experiences will also enchant attendees, most notably with a dinner for six at Maison Nur, the French-American fine dining restaurant created by Nur Khan. Known for its elegant atmosphere and exceptional cuisine, Maison Nur blends contemporary refinement with classic artistry. The winning bidders will enjoy an evening of gastronomic excellence in a setting defined by intimacy and sophistication.

Art lovers and patrons of culture will find inspiration in a private guided tour for ten at the Museum of Modern Art. This behind-the-scenes experience offers a rare glimpse into the curatorial world that shapes one of the most influential institutions in global art. Guests will engage with the museum’s history and vision in a uniquely personal setting that few have the chance to encounter.

The auction also includes exclusive tickets to the opening night of Bernadette, the Musical, an anticipated new stage production that blends theatrical innovation with emotional storytelling. For theatre enthusiasts, this promises an evening of artistic excitement and first-night glamour.

Beyond these marquee items, the White Cross Ball silent auction features a rich assortment of additional offerings, each selected with the same care and commitment to excellence. Collectors, philanthropists, and patrons alike will find opportunities that unite enjoyment with purpose, ensuring that every bid contributes to the continuation of the Order of Malta’s mission.

For centuries, the Order of Malta has stood as a global symbol of compassion and faith in action. Its volunteers and medical professionals work across continents to provide assistance to the poor, the sick, and the displaced. The White Cross Ball, among its most recognized events in the United States, channels the generosity of its attendees into tangible impact—funding hospitals, clinics, and relief efforts that reach communities in need around the world.

The Ball itself has long been a fixture of New York’s philanthropic calendar. Distinguished guests, among them figures from diplomacy, society, and the arts, attend not only to support charitable work but also to uphold a tradition of elegance rooted in service. Each year’s gathering is marked by formal attire, candlelit dining, and a spirit of goodwill that recalls the earliest charitable banquets of Europe’s historic orders.

The 2025 White Cross Ball promises to continue this lineage with renewed energy. Attendees will experience an evening that balances grandeur with purpose, where each moment of festivity contributes to a legacy of mercy and healing. The silent auction serves as a modern extension of that same tradition, transforming luxury into an instrument of compassion.

By inviting participation from around the world through its online platform, the Ball extends its reach beyond the ballroom, enabling a broader community to share in its mission. Whether through bidding on a Mediterranean voyage or an evening of fine dining, participants affirm their belief in the enduring value of charity united with culture.

The White Cross Ball’s organizers, under the patronage of the Order of Malta’s New York committee, continue to refine the event’s balance between opulence and service. Their careful curation of experiences and their dedication to philanthropic excellence ensure that the event remains one of the city’s most anticipated occasions each autumn.

As November approaches, the anticipation surrounding the Ball reflects more than excitement for an elegant night. It expresses the continued vitality of an idea that has endured through centuries: that beauty, generosity, and service are most meaningful when shared. In the interplay between grandeur and goodwill, the White Cross Ball stands as a reminder that the heart of charity is not in what is given but in how it is given—with grace, dignity, and enduring care.

 

Prince Mario-Max Schaumburg-Lippe: Come Support The Waxman Cancer Research Foundation Gala on October 22nd!

Science and Celebration Unite at the Samuel Waxman Cancer Research Foundation Gala

A night of discovery, generosity, and global collaboration will illuminate New York as the Samuel Waxman Cancer Research Foundation hosts its 28th Annual Collaborating for a Cure fundraiser.

New Yorks PR Powerhouse Norah Lawlor has just informed us that on Wednesday, October 22, 2025, the Samuel Waxman Cancer Research Foundation will mark a remarkable chapter in its legacy of scientific progress and philanthropy. AND we want your support! The 28th Annual Collaborating for a Cure event, themed A Celebration of Breakthroughs, will take place at Apella, located at 450 East 29th Street in New York City. From 6:30 to 9:30 in the evening, supporters, scientists, and leaders from across industries will gather in a shared mission: to accelerate the discovery of cancer cures through innovation and unity.

This year’s gala will carry special meaning as it not only celebrates nearly five decades of transformative research funding but also unveils the Samuel Waxman Institute for Aging & Cancer. The newly established institute represents a pioneering effort in medical science, the first of its kind to study the intersection of aging and cancer in an integrated way. It embodies the Foundation’s enduring commitment to exploring new frontiers in cancer prevention and treatment by uniting brilliant minds across the globe.

All funds raised during the evening will be matched dollar-for-dollar through the Foundation’s partnership with The Mark Foundation for Cancer Research, effectively doubling the resources available to support groundbreaking scientific grants. The collaboration between these two organizations continues to expand the potential of translational research, ensuring that promising laboratory discoveries can evolve into real-world therapies faster than ever before.

The evening will also serve as a celebration of individuals whose contributions reflect the Foundation’s core values of leadership, compassion, and impact. Honorees include Jean Shafiroff, recognized as Philanthropist of the Year for her extensive charitable work and influence across numerous causes; Robert Wiener, Chairman Emeritus of Maxx Properties, also named Philanthropist of the Year for his longstanding commitment to philanthropy; and Dr. Jeffrey Settleman, Senior Vice President and Chief Scientific Officer for Oncology Research and Development at Pfizer, who will receive the prestigious Breakthrough Science Award for his exceptional contributions to advancing cancer research.

Over nearly three decades, the Collaborating for a Cure fundraiser has become one of New York’s most inspiring philanthropic evenings. Known for blending elegance with purpose, the event draws a distinguished audience from the worlds of science, business, fashion, and entertainment. Guests will enjoy an exquisite seated dinner accompanied by a program that highlights the latest achievements of SWCRF-supported researchers, showcasing how collaboration continues to redefine what is possible in cancer prevention, diagnosis, and treatment.

The Samuel Waxman Cancer Research Foundation stands as a model of sustained scientific partnership. Since its founding in 1976, the organization has awarded more than $120 million to over 200 researchers worldwide. Central to its success is the Foundation’s signature model, the Institute Without Walls, which fosters open collaboration among global investigators, encouraging them to share data, techniques, and discoveries in real time. This approach has dramatically accelerated the pace at which cancer research progresses, bridging disciplines and national boundaries in the pursuit of cures.

At the heart of the Foundation’s philosophy is the understanding that collaboration fuels discovery. Through the decades, SWCRF has consistently sought to fund innovative science that identifies and corrects abnormal gene functions responsible for cancer while minimizing treatment toxicity for patients. The organization’s impact extends far beyond traditional grantmaking, cultivating a global community of scientists united by the belief that cooperation is essential to eradicating cancer.

As the evening unfolds at Apella, attendees will be reminded of the enduring power of partnership — between scientists and philanthropists, between institutions and individuals, and between innovation and compassion. The setting, overlooking the East River, offers a fitting backdrop for a night that honors visionaries shaping the future of medicine.

The celebration’s timing also highlights an important evolution in the Foundation’s journey. With the formal introduction of the Samuel Waxman Institute for Aging & Cancer, the Foundation is ushering in a new era of scientific exploration. By bringing together researchers who specialize in both aging and oncology, this initiative seeks to understand how the biological processes of aging influence the development and progression of cancer. The insights generated through this work are expected to transform how scientists approach prevention strategies and therapeutic design for the years ahead.

The honorees each reflect the multidimensional spirit of the Foundation’s work. Jean Shafiroff, whose philanthropic reach spans healthcare, animal welfare, and education, continues to embody the intersection of generosity and advocacy. Robert Wiener’s influence as both a business leader and humanitarian reflects the vital role that private sector visionaries play in supporting life-changing research. Dr. Jeffrey Settleman’s leadership at Pfizer underscores how industry innovation and academic collaboration can work in concert to move science forward.

Each year, Collaborating for a Cure not only raises funds but also raises awareness of the profound impact that sustained scientific investment can achieve. The event’s atmosphere combines the refinement of a gala with the sense of urgency and optimism that accompanies groundbreaking research. Guests leave with a deeper understanding that progress in oncology is not measured solely in laboratory milestones but also in the lives extended and the families preserved through research-driven discovery.

The partnership between SWCRF and The Mark Foundation for Cancer Research serves as a model for modern philanthropy. By aligning missions and resources, these organizations demonstrate how cooperation between charitable and scientific entities can double the reach and impact of every contribution. Their shared vision ensures that funds raised in a single evening have the power to transform entire research portfolios and open new paths toward cancer cures.

Throughout the evening, attendees will have the opportunity to hear about recent advancements supported by SWCRF grants, each representing a step closer to transforming cancer from a life-threatening diagnosis into a manageable condition. From molecular insights into tumor resistance to precision therapies tailored to genetic profiles, the work funded by the Foundation exemplifies how sustained investment in science yields tangible hope.

As the 28th annual event approaches, anticipation builds among supporters who have witnessed the Foundation’s growth from a pioneering idea into a global force for scientific collaboration. The Samuel Waxman Cancer Research Foundation remains guided by its founder’s enduring belief that the cure for cancer will be discovered not by isolated efforts, but through collective determination and shared discovery.

For those wishing to join this celebration of progress and possibility, details and ticket information are available at www.waxmancancer.org/gala.

Dr. Samuel Waxman’s journey is defined by both scientific ambition and humanitarian vision. From his early days immersed in rigorous medical training to the founding of the Samuel Waxman Cancer Research Foundation and decades of global collaborations, his story is one of steady advancement toward the bold objective of eradicating cancer.

Born and raised in New York City, Samuel Waxman completed an undergraduate degree at Cornell University in 1957 and earned his M.D. at the State University of New York Downstate Medical Center in 1963. He then undertook residency and fellowship training at Mount Sinai Hospital in New York, where he would forge his career as an oncologist and hematologist.

In subsequent years he joined the faculty of the Icahn School of Medicine at Mount Sinai, rising to become the Zena and Michael A. Wiener Professor of Medicine (Cancer), Distinguished Service Professor of Medicine, Hematology and Medical Oncology, and Distinguished Service Professor of Oncological Sciences.

Even as the academic titles accumulated, Dr. Waxman’s attention stayed fixed on a key scientific frontier: the abnormal differentiation of cells that leads to leukemia and other cancers. He was among the first to champion “differentiation therapy” — a concept that instead of aiming merely to kill cancerous cells, seeks to restore them toward normal maturation.

In 1976, recognizing the critical need for flexible funding and cross‐institutional collaboration in cancer research, Dr. Waxman established the Samuel Waxman Cancer Research Foundation (SWCRF). The foundation was born out of a simple conversation with a donor who asked whether Dr. Waxman had ever thought of creating an organization to fund his work. From that moment, the foundation became his vehicle to marshal resources, build networks and drive research that crossed traditional institutional boundaries.

Under Dr. Waxman’s leadership the foundation adopted a philosophy he long held: science progresses fastest when investigators and laboratories with complementary strengths join forces. The SWCRF’s “Institute Without Walls” model embodies this by funding collaborations rather than isolated labs, enabling teams from North America, Europe and Asia to work in concert on cancer’s most intractable mysteries.

One of Dr. Waxman’s landmark achievements came in the treatment of acute promyelocytic leukemia (APL). Working with colleagues in China — notably at the Shanghai Institute of Hematology — he helped pioneer treatment regimens using all‐trans retinoic acid (ATRA) and arsenic trioxide. These therapies transformed APL from a near-certain fatal disease into one with survival rates above 90 percent.

Beyond leukemia, Dr. Waxman continued to apply differentiation‐based strategies, investigating how to correct abnormal gene functions, target regulatory proteins and even explore nutritional factors in cancer cell biology. His work linked vitamins such as A, B12 and folic acid to DNA synthesis and gene regulation, thus bridging basic biochemistry with clinical oncology.

Over the course of his career Dr. Waxman has authored more than 300 scientific papers, written chapters in textbooks on hematology and chemotherapy, and published books such as Differentiation Therapy and The Leukemia Cell. As founder and scientific director of SWCRF, he has overseen funding of tens of millions of dollars and fostered a global network of cancer researchers.

Equally important is Dr. Waxman’s role as mentor, connector and visionary. He has convened international conferences on differentiation therapy, set up honorary professorships (including at Shanghai Jiao Tong University) and guided young scientists into collaborative frameworks long before such models were common.

Dr. Waxman’s story is rooted in medicine yet shaped by global possibility. His early work in New York laboratories matured into partnerships that spanned oceans. His focus on differentiation therapy opened new pathways when cytotoxic chemotherapy seemed the only option. His foundation-building created infrastructure not only for his own laboratory but for research ecosystems that persist.

In recent years Dr. Waxman has held the titles of Professor Emeritus in Medicine, Hematology/Oncology and Oncological Sciences at Mount Sinai, while continuing active engagement in research and foundation work. His vision remains firmly on the future: therapies that are minimally toxic, personalized, gene‐function‐correcting, and globally accessible.

His legacy will persist well beyond his own lab: a generation of scientists seeing cancer not merely as a target to be destroyed but as a cellular programme to be re-educated; a network of collaborations crossing disciplinary and geographic borders; and therapies seeded from his foundational work that are now standard of care.

Dr. Samuel Waxman’s life is a testament to perseverance, innovation and the conviction that scientific progress is best achieved through cooperation rather than competition. His career exemplifies how a single patient‐centre orientation — that every cancer patient deserves the best possible future — can drive decades of inquiry, fund-raising, mentorship and global outreach.

In an era where the promise of cancer cure remains both urgent and complex, Dr. Waxman’s path reminds us that breakthroughs frequently come at the intersection of biology, collaboration and vision.

Samuel Waxman Cancer Research Foundation, Samuel Waxman Institute for Aging & Cancer, The Mark Foundation for Cancer Research, Jean Shafiroff, Robert Wiener, Jeffrey Settleman, Pfizer, Maxx Properties, Apella, New York City, Lawlor Media Group, Norah Lawlor, Collaborating for a Cure, A Celebration of Breakthroughs, Cancer Research, Oncology, Aging and Cancer, Cancer Prevention, Gene Function, Philanthropy, Global Science, Biomedical Innovation, Medical Research, New York Fundraisers, Health Leadership, Cancer Collaboration, Life Sciences, Precision Medicine, Molecular Biology, Cancer Treatment, Medical Innovation, Scientific Discovery, Global Health